Amin Mihramane, Prof. S Rogers

Palliative chemotherapy is often a treatment designed for terminal cancer patients to essentially prolong survival and ease symptoms. Despite this, there is growing concern that certain therapies risks and detrimental factors are far outweighing the positives of prolonging a reduced quality of life. Despite the project being in its early stages it will be addressing the changing use of chemotherapy within the large cluster of data between Aintree and Clatterbridge hospital. The main aim will be to see if the overall holistic treatment can be improved in reflection of the results - project overseen by prof Rogers OMFS Will most likely be a cohort study with Clinical characteristics…year of diagnosis, age, gender, site of oral cancer, stage…ideally something on comorbidity (might be difficult historically) What chemo agents When used – palliative, curative, time after operation, before during after RT acute side affects….late effects…ORN etc any HRQOL data…. Crude survival

Results are still pending and so conclusion has to be formalised It must be noted* we are building the newer patients so as a audit to be published the abstract and presentation is a flavour as the project will take 6 months I expect to get the data, check it, analyse it and submit Presentation/poster will be ready for January.

Information

All content is accurate at time of writing but may become inaccurate over time. Any content images are the copyright of The JTG, or their respective rights holders if otherwise mentioned, and cannot be used without prior permission. Please contact us for content queries. 

 

Contact Us

  +44(0) 207 405 8074
  This email address is being protected from spambots. You need JavaScript enabled to view it.
  Junior Trainees Group
     British Association of Oral & Maxillofacial Surgeons
     Royal College of Surgeons of England
     35/43 Lincoln's Inn Fields, London, WC2A 3PE